Skip to main content
SanofiPatent grant

Sanofi Biotechnology was granted a patent for IL-4R allergy treatments

Source: Autobound Signal API · 89 signals tracked for Sanofi · updated

Get Sanofi's live signals in Claude or ChatGPT, or by API

AskWhat changed at Sanofi this week? Use Autobound signals for sanofi.com.

What happened

In November 2026 Sanofi Biotechnology patented an antibody-based approach for preventing or treating allergic disease in patients with conditions such as asthma, eczema, or allergic rhinitis.

Source

Abstract

The present invention provides methods for preventing or treating allergy. Also provided are methods for reducing the susceptibility to an allergen in a subject in need thereof. In certain embodiments, the subject has a disease or disorder selected from the group consisting of atopic dermatitis, asthma, allergic rhinitis, and eosinophilic esophagitis. The methods of the present invention comprise administering to a subject in need thereof a pharmaceutical composition comprising an interleukin-4 receptor (IL-4R) antagonist such as an anti-IL-4R antibody.

patents.google.com/patent/US12788797Read the full source

Extracted by Autobound

From the Signal API record
Signal
Patent grant

What this signalsA new patent often shows where a company is putting its R&D budget.

Grant date
Nov 10, 2026
Inventors
Jennifer D. Hamilton, Brian N. Swanson
Patent number
US12788797
Assignee
Sanofi biotechnology

The full record

From the Signal API record

People

  • Jennifer D. HamiltonInventor
  • Brian N. SwansonInventor

Details

Primary CPC class
A61K 38/1774
USPTO assignee
Sanofi biotechnology
What the invention does
A treatment that blocks the interleukin-4 receptor to reduce the body’s sensitivity and reaction to allergens.

Topics and mentions

Tags

  • Intellectual Property
  • Research & Development
  • Pharmaceuticals
  • Medical Research

Technologies named

  • IL-4R antagonists
  • immunotherapy
  • allergy treatment

Extraction

Detected
Nov 11, 2026
signal_type
patents-company
signal_subtype
patentGrant

Use this data

Get every patent signal for Sanofi and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Sanofi this week?”

  2. Send it to your own tools

    The Signal API returns patent signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full patents-company record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/1880d09c-eb3a-5fa6-8fd3-2c587f257195 returns this record as JSON. POST /v1/companies/enrich returns every signal for sanofi.com.

{
  "signal_id": "1880d09c-eb3a-5fa6-8fd3-2c587f257195",
  "signal_type": "patents-company",
  "signal_subtype": "patentGrant",
  "detected_at": "2026-11-11T14:57:09+00:00",
  "company": {
    "name": "Sanofi",
    "domain": "sanofi.com"
  },
  "data": {
    "cpc": [
      {
        "code": "A61K 38/1774"
      },
      {
        "code": "A61K 9/0019"
      },
      {
        "code": "A61K 39/00"
      },
      {
        "code": "A61P 17/00"
      },
      {
        "code": "A61P 37/08"
      }
    ],
    "tags": [
      "Intellectual Property",
      "Research & Development",
      "Pharmaceuticals",
      "Medical Research"
    ],
    "detail": "In November 2026 Sanofi Biotechnology patented an antibody-based approach for preventing or treating allergic disease in patients with conditions such as asthma, eczema, or allergic rhinitis.",
    "summary": "Sanofi Biotechnology was granted a patent for IL-4R allergy treatments",
    "event_at": "2026-11-10",
    "inventors": [
      {
        "name": "Jennifer D. Hamilton",
        "status": "resolved",
        "is_primary": true,
        "linkedin_url": "https://www.linkedin.com/in/jennifer-davidson-hamilton-974b4910"
      },
      {
        "name": "Brian N. Swanson",
        "status": "unresolved",
        "is_primary": false
      }
    ],
    "event_kind": "grant_date",
    "grant_date": "2026-11-10",
    "source_url": "https://patents.google.com/patent/US12788797",
    "cpc_primary": {
      "code": "A61K 38/1774"
    },
    "patent_title": "Methods for preventing or treating allergy by administering an IL-4R antagonist",
    "patent_number": "US12788797",
    "uspto_assignee": "SANOFI BIOTECHNOLOGY",
    "patent_abstract": "The present invention provides methods for preventing or treating allergy. Also provided are methods for reducing the susceptibility to an allergen in a subject in need thereof. In certain embodiments, the subject has a disease or disorder selected from the group consisting of atopic dermatitis, asthma, allergic rhinitis, and eosinophilic esophagitis. The methods of the present invention comprise administering to a subject in need thereof a pharmaceutical composition comprising an interleukin-4 receptor (IL-4R) antagonist such as an anti-IL-4R antibody.",
    "precision_class": "structural",
    "invention_explanation": "A treatment that blocks the interleukin-4 receptor to reduce the body’s sensitivity and reaction to allergens.",
    "technologies_mentioned": [
      "IL-4R antagonists",
      "immunotherapy",
      "allergy treatment"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.